XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOW FROM OPERATING ACTIVITIES    
Net income $ 2,255 $ 3,198
Adjustments to reconcile net income to net cash provided by operating activities:    
Discontinued operations, net 0 (182)
Depreciation, depletion and amortization of assets 5,914 5,394
Deferred income tax provision (benefit) 1 (182)
Asset impairments and related items 0 21
(Gains) losses on sales of assets and other, net (13) 52
Other noncash charges to income 685 339
Changes in operating assets and liabilities:    
(Increase) decrease in trade receivables 352 (532)
(Increase) decrease in inventories 16 (226)
(Increase) decrease in other current assets (76) 219
Decrease in accounts payable and accrued liabilities (1,067) (430)
Increase (decrease) in current domestic and foreign income taxes (169) 512
Operating cash flow from continuing operations 7,898 8,183
Operating cash flow from discontinued operations, net of taxes 0 (100)
Net cash provided by operating activities 7,898 8,083
CASH FLOW FROM INVESTING ACTIVITIES    
Capital expenditures (5,674) (5,237)
Change in capital accrual (87) (39)
Purchases of assets, businesses and equity investments, net (231) (9,037)
Proceeds from sales of assets, net 2,230 1,662
Equity investments and other, net (227) (149)
Net cash used by investing activities (3,989) (12,800)
CASH FLOW FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net 0 9,612
Payments of long-term debt, net (3,584) (4,007)
Proceeds from issuance of common stock 948 571
Purchases of treasury stock 0 (9)
Cash dividends paid on common and preferred stock (1,186) (1,069)
Contributions from noncontrolling interest 153 146
Payment for taxes related to stock-based award settlement (63) (103)
Other financing, net (138) (95)
Net cash provided (used) by financing activities (3,870) 5,046
Increase in cash, cash equivalents, restricted cash and restricted cash equivalents 39 329
Cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of period 2,157 1,464
Cash, cash equivalents, restricted cash and restricted cash equivalents — end of period $ 2,196 $ 1,793